.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Emma Fletcher

Sydney / AU

Garvan Institute of Medical Research

Vortrag

01.06.2023
14:59 – 15:06 5 Min. 2 Min.
LT 3-3
Bone-targeting bisphosphonates may boost immune responses to pulmonary infection by inhibiting the mevalonate pathway in alveolar macrophages
Metabolic regulation of innate immunity, Pattern recognition receptors and inflammasomes

Weitere Beteiligungen

01.06.2023
14:59 – 15:06 5 Min. 2 Min.
LT 3-3
Bone-targeting bisphosphonates may boost immune responses to pulmonary infection by inhibiting the mevalonate pathway in alveolar macrophages
Metabolic regulation of innate immunity, Pattern recognition receptors and inflammasomes